The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Peramivir is a synthetic cyclopentane derivative. The groups connected to the ring include hydrophilic carboxyl and guanidine groups, as well as hydrophobic isopentyl and acetamido groups. The four groups with different polarities act on Different active site regions in the NA structure of influenza virus. This medicine is suitable for treating influenza A and is mainly administered intravenously in the form of sodium chloride solution.
The global Peramivir market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Peramivir is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Peramivir is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Peramivir include BioCryst Pharmaceuticals, Green Cross Pharma, Shionogi Co., NeoPharm, Moksha8 Pharma, NT Pharma, Merck, Hikma Pharmaceuticals and Hunan Nucien Pharmaceutical Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Peramivir, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peramivir.
Report Scope
The Peramivir market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Peramivir market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peramivir manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BioCryst Pharmaceuticals
Green Cross Pharma
Shionogi Co.
NeoPharm
Moksha8 Pharma
NT Pharma
Merck
Hikma Pharmaceuticals
Hunan Nucien Pharmaceutical Co., Ltd.
SCOLR Pharma
Segment by Type
Solution
Solid
Segment by Application
Influenza A Treatment
Influenza B Treatment
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Peramivir manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Peramivir in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Peramivir is a synthetic cyclopentane derivative. The groups connected to the ring include hydrophilic carboxyl and guanidine groups, as well as hydrophobic isopentyl and acetamido groups. The four groups with different polarities act on Different active site regions in the NA structure of influenza virus. This medicine is suitable for treating influenza A and is mainly administered intravenously in the form of sodium chloride solution.
The global Peramivir market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Peramivir is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Peramivir is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Peramivir include BioCryst Pharmaceuticals, Green Cross Pharma, Shionogi Co., NeoPharm, Moksha8 Pharma, NT Pharma, Merck, Hikma Pharmaceuticals and Hunan Nucien Pharmaceutical Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Peramivir, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peramivir.
Report Scope
The Peramivir market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Peramivir market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peramivir manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BioCryst Pharmaceuticals
Green Cross Pharma
Shionogi Co.
NeoPharm
Moksha8 Pharma
NT Pharma
Merck
Hikma Pharmaceuticals
Hunan Nucien Pharmaceutical Co., Ltd.
SCOLR Pharma
Segment by Type
Solution
Solid
Segment by Application
Influenza A Treatment
Influenza B Treatment
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Peramivir manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Peramivir in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Peramivir Market Overview
1.1 Product Overview and Scope of Peramivir
1.2 Peramivir Segment by Type
1.2.1 Global Peramivir Market Value Comparison by Type (2024-2030)
1.2.2 Solution
1.2.3 Solid
1.3 Peramivir Segment by Application
1.3.1 Global Peramivir Market Value by Application: (2024-2030)
1.3.2 Influenza A Treatment
1.3.3 Influenza B Treatment
1.4 Global Peramivir Market Size Estimates and Forecasts
1.4.1 Global Peramivir Revenue 2019-2030
1.4.2 Global Peramivir Sales 2019-2030
1.4.3 Global Peramivir Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Peramivir Market Competition by Manufacturers
2.1 Global Peramivir Sales Market Share by Manufacturers (2019-2024)
2.2 Global Peramivir Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Peramivir Average Price by Manufacturers (2019-2024)
2.4 Global Peramivir Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Peramivir, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Peramivir, Product Type & Application
2.7 Peramivir Market Competitive Situation and Trends
2.7.1 Peramivir Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Peramivir Players Market Share by Revenue
2.7.3 Global Peramivir Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Peramivir Retrospective Market Scenario by Region
3.1 Global Peramivir Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Peramivir Global Peramivir Sales by Region: 2019-2030
3.2.1 Global Peramivir Sales by Region: 2019-2024
3.2.2 Global Peramivir Sales by Region: 2025-2030
3.3 Global Peramivir Global Peramivir Revenue by Region: 2019-2030
3.3.1 Global Peramivir Revenue by Region: 2019-2024
3.3.2 Global Peramivir Revenue by Region: 2025-2030
3.4 North America Peramivir Market Facts & Figures by Country
3.4.1 North America Peramivir Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Peramivir Sales by Country (2019-2030)
3.4.3 North America Peramivir Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Peramivir Market Facts & Figures by Country
3.5.1 Europe Peramivir Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Peramivir Sales by Country (2019-2030)
3.5.3 Europe Peramivir Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Peramivir Market Facts & Figures by Country
3.6.1 Asia Pacific Peramivir Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Peramivir Sales by Country (2019-2030)
3.6.3 Asia Pacific Peramivir Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Peramivir Market Facts & Figures by Country
3.7.1 Latin America Peramivir Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Peramivir Sales by Country (2019-2030)
3.7.3 Latin America Peramivir Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Peramivir Market Facts & Figures by Country
3.8.1 Middle East and Africa Peramivir Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Peramivir Sales by Country (2019-2030)
3.8.3 Middle East and Africa Peramivir Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Peramivir Sales by Type (2019-2030)
4.1.1 Global Peramivir Sales by Type (2019-2024)
4.1.2 Global Peramivir Sales by Type (2025-2030)
4.1.3 Global Peramivir Sales Market Share by Type (2019-2030)
4.2 Global Peramivir Revenue by Type (2019-2030)
4.2.1 Global Peramivir Revenue by Type (2019-2024)
4.2.2 Global Peramivir Revenue by Type (2025-2030)
4.2.3 Global Peramivir Revenue Market Share by Type (2019-2030)
4.3 Global Peramivir Price by Type (2019-2030)
5 Segment by Application
5.1 Global Peramivir Sales by Application (2019-2030)
5.1.1 Global Peramivir Sales by Application (2019-2024)
5.1.2 Global Peramivir Sales by Application (2025-2030)
5.1.3 Global Peramivir Sales Market Share by Application (2019-2030)
5.2 Global Peramivir Revenue by Application (2019-2030)
5.2.1 Global Peramivir Revenue by Application (2019-2024)
5.2.2 Global Peramivir Revenue by Application (2025-2030)
5.2.3 Global Peramivir Revenue Market Share by Application (2019-2030)
5.3 Global Peramivir Price by Application (2019-2030)
6 Key Companies Profiled
6.1 BioCryst Pharmaceuticals
6.1.1 BioCryst Pharmaceuticals Corporation Information
6.1.2 BioCryst Pharmaceuticals Description and Business Overview
6.1.3 BioCryst Pharmaceuticals Peramivir Sales, Revenue and Gross Margin (2019-2024)
6.1.4 BioCryst Pharmaceuticals Peramivir Product Portfolio
6.1.5 BioCryst Pharmaceuticals Recent Developments/Updates
6.2 Green Cross Pharma
6.2.1 Green Cross Pharma Corporation Information
6.2.2 Green Cross Pharma Description and Business Overview
6.2.3 Green Cross Pharma Peramivir Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Green Cross Pharma Peramivir Product Portfolio
6.2.5 Green Cross Pharma Recent Developments/Updates
6.3 Shionogi Co.
6.3.1 Shionogi Co. Corporation Information
6.3.2 Shionogi Co. Description and Business Overview
6.3.3 Shionogi Co. Peramivir Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Shionogi Co. Peramivir Product Portfolio
6.3.5 Shionogi Co. Recent Developments/Updates
6.4 NeoPharm
6.4.1 NeoPharm Corporation Information
6.4.2 NeoPharm Description and Business Overview
6.4.3 NeoPharm Peramivir Sales, Revenue and Gross Margin (2019-2024)
6.4.4 NeoPharm Peramivir Product Portfolio
6.4.5 NeoPharm Recent Developments/Updates
6.5 Moksha8 Pharma
6.5.1 Moksha8 Pharma Corporation Information
6.5.2 Moksha8 Pharma Description and Business Overview
6.5.3 Moksha8 Pharma Peramivir Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Moksha8 Pharma Peramivir Product Portfolio
6.5.5 Moksha8 Pharma Recent Developments/Updates
6.6 NT Pharma
6.6.1 NT Pharma Corporation Information
6.6.2 NT Pharma Description and Business Overview
6.6.3 NT Pharma Peramivir Sales, Revenue and Gross Margin (2019-2024)
6.6.4 NT Pharma Peramivir Product Portfolio
6.6.5 NT Pharma Recent Developments/Updates
6.7 Merck
6.6.1 Merck Corporation Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Peramivir Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck Peramivir Product Portfolio
6.7.5 Merck Recent Developments/Updates
6.8 Hikma Pharmaceuticals
6.8.1 Hikma Pharmaceuticals Corporation Information
6.8.2 Hikma Pharmaceuticals Description and Business Overview
6.8.3 Hikma Pharmaceuticals Peramivir Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Hikma Pharmaceuticals Peramivir Product Portfolio
6.8.5 Hikma Pharmaceuticals Recent Developments/Updates
6.9 Hunan Nucien Pharmaceutical Co., Ltd.
6.9.1 Hunan Nucien Pharmaceutical Co., Ltd. Corporation Information
6.9.2 Hunan Nucien Pharmaceutical Co., Ltd. Description and Business Overview
6.9.3 Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Product Portfolio
6.9.5 Hunan Nucien Pharmaceutical Co., Ltd. Recent Developments/Updates
6.10 SCOLR Pharma
6.10.1 SCOLR Pharma Corporation Information
6.10.2 SCOLR Pharma Description and Business Overview
6.10.3 SCOLR Pharma Peramivir Sales, Revenue and Gross Margin (2019-2024)
6.10.4 SCOLR Pharma Peramivir Product Portfolio
6.10.5 SCOLR Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Peramivir Industry Chain Analysis
7.2 Peramivir Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Peramivir Production Mode & Process
7.4 Peramivir Sales and Marketing
7.4.1 Peramivir Sales Channels
7.4.2 Peramivir Distributors
7.5 Peramivir Customers
8 Peramivir Market Dynamics
8.1 Peramivir Industry Trends
8.2 Peramivir Market Drivers
8.3 Peramivir Market Challenges
8.4 Peramivir Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Peramivir Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Peramivir Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Peramivir Market Competitive Situation by Manufacturers in 2023
Table 4. Global Peramivir Sales (Tons) of Key Manufacturers (2019-2024)
Table 5. Global Peramivir Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Peramivir Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Peramivir Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Peramivir Average Price (US$/Kg) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Peramivir, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Peramivir, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Peramivir, Product Type & Application
Table 12. Global Key Manufacturers of Peramivir, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Peramivir by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peramivir as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Peramivir Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Peramivir Sales by Region (2019-2024) & (Tons)
Table 18. Global Peramivir Sales Market Share by Region (2019-2024)
Table 19. Global Peramivir Sales by Region (2025-2030) & (Tons)
Table 20. Global Peramivir Sales Market Share by Region (2025-2030)
Table 21. Global Peramivir Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Peramivir Revenue Market Share by Region (2019-2024)
Table 23. Global Peramivir Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Peramivir Revenue Market Share by Region (2025-2030)
Table 25. North America Peramivir Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Peramivir Sales by Country (2019-2024) & (Tons)
Table 27. North America Peramivir Sales by Country (2025-2030) & (Tons)
Table 28. North America Peramivir Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Peramivir Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Peramivir Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Peramivir Sales by Country (2019-2024) & (Tons)
Table 32. Europe Peramivir Sales by Country (2025-2030) & (Tons)
Table 33. Europe Peramivir Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Peramivir Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Peramivir Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Peramivir Sales by Region (2019-2024) & (Tons)
Table 37. Asia Pacific Peramivir Sales by Region (2025-2030) & (Tons)
Table 38. Asia Pacific Peramivir Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Peramivir Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Peramivir Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Peramivir Sales by Country (2019-2024) & (Tons)
Table 42. Latin America Peramivir Sales by Country (2025-2030) & (Tons)
Table 43. Latin America Peramivir Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Peramivir Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Peramivir Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Peramivir Sales by Country (2019-2024) & (Tons)
Table 47. Middle East & Africa Peramivir Sales by Country (2025-2030) & (Tons)
Table 48. Middle East & Africa Peramivir Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Peramivir Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Peramivir Sales (Tons) by Type (2019-2024)
Table 51. Global Peramivir Sales (Tons) by Type (2025-2030)
Table 52. Global Peramivir Sales Market Share by Type (2019-2024)
Table 53. Global Peramivir Sales Market Share by Type (2025-2030)
Table 54. Global Peramivir Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Peramivir Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Peramivir Revenue Market Share by Type (2019-2024)
Table 57. Global Peramivir Revenue Market Share by Type (2025-2030)
Table 58. Global Peramivir Price (US$/Kg) by Type (2019-2024)
Table 59. Global Peramivir Price (US$/Kg) by Type (2025-2030)
Table 60. Global Peramivir Sales (Tons) by Application (2019-2024)
Table 61. Global Peramivir Sales (Tons) by Application (2025-2030)
Table 62. Global Peramivir Sales Market Share by Application (2019-2024)
Table 63. Global Peramivir Sales Market Share by Application (2025-2030)
Table 64. Global Peramivir Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Peramivir Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Peramivir Revenue Market Share by Application (2019-2024)
Table 67. Global Peramivir Revenue Market Share by Application (2025-2030)
Table 68. Global Peramivir Price (US$/Kg) by Application (2019-2024)
Table 69. Global Peramivir Price (US$/Kg) by Application (2025-2030)
Table 70. BioCryst Pharmaceuticals Corporation Information
Table 71. BioCryst Pharmaceuticals Description and Business Overview
Table 72. BioCryst Pharmaceuticals Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 73. BioCryst Pharmaceuticals Peramivir Product
Table 74. BioCryst Pharmaceuticals Recent Developments/Updates
Table 75. Green Cross Pharma Corporation Information
Table 76. Green Cross Pharma Description and Business Overview
Table 77. Green Cross Pharma Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 78. Green Cross Pharma Peramivir Product
Table 79. Green Cross Pharma Recent Developments/Updates
Table 80. Shionogi Co. Corporation Information
Table 81. Shionogi Co. Description and Business Overview
Table 82. Shionogi Co. Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 83. Shionogi Co. Peramivir Product
Table 84. Shionogi Co. Recent Developments/Updates
Table 85. NeoPharm Corporation Information
Table 86. NeoPharm Description and Business Overview
Table 87. NeoPharm Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 88. NeoPharm Peramivir Product
Table 89. NeoPharm Recent Developments/Updates
Table 90. Moksha8 Pharma Corporation Information
Table 91. Moksha8 Pharma Description and Business Overview
Table 92. Moksha8 Pharma Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 93. Moksha8 Pharma Peramivir Product
Table 94. Moksha8 Pharma Recent Developments/Updates
Table 95. NT Pharma Corporation Information
Table 96. NT Pharma Description and Business Overview
Table 97. NT Pharma Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 98. NT Pharma Peramivir Product
Table 99. NT Pharma Recent Developments/Updates
Table 100. Merck Corporation Information
Table 101. Merck Description and Business Overview
Table 102. Merck Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 103. Merck Peramivir Product
Table 104. Merck Recent Developments/Updates
Table 105. Hikma Pharmaceuticals Corporation Information
Table 106. Hikma Pharmaceuticals Description and Business Overview
Table 107. Hikma Pharmaceuticals Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 108. Hikma Pharmaceuticals Peramivir Product
Table 109. Hikma Pharmaceuticals Recent Developments/Updates
Table 110. Hunan Nucien Pharmaceutical Co., Ltd. Corporation Information
Table 111. Hunan Nucien Pharmaceutical Co., Ltd. Description and Business Overview
Table 112. Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 113. Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Product
Table 114. Hunan Nucien Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 115. SCOLR Pharma Corporation Information
Table 116. SCOLR Pharma Description and Business Overview
Table 117. SCOLR Pharma Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 118. SCOLR Pharma Peramivir Product
Table 119. SCOLR Pharma Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Peramivir Distributors List
Table 123. Peramivir Customers List
Table 124. Peramivir Market Trends
Table 125. Peramivir Market Drivers
Table 126. Peramivir Market Challenges
Table 127. Peramivir Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Peramivir
Figure 2. Global Peramivir Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Peramivir Market Share by Type in 2023 & 2030
Figure 4. Solution Product Picture
Figure 5. Solid Product Picture
Figure 6. Global Peramivir Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Peramivir Market Share by Application in 2023 & 2030
Figure 8. Influenza A Treatment
Figure 9. Influenza B Treatment
Figure 10. Global Peramivir Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Peramivir Market Size (2019-2030) & (US$ Million)
Figure 12. Global Peramivir Sales (2019-2030) & (Tons)
Figure 13. Global Peramivir Average Price (US$/Kg) & (2019-2030)
Figure 14. Peramivir Report Years Considered
Figure 15. Peramivir Sales Share by Manufacturers in 2023
Figure 16. Global Peramivir Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Peramivir Players: Market Share by Revenue in 2023
Figure 18. Peramivir Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Peramivir Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Peramivir Sales Market Share by Country (2019-2030)
Figure 21. North America Peramivir Revenue Market Share by Country (2019-2030)
Figure 22. U.S. Peramivir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Peramivir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Peramivir Sales Market Share by Country (2019-2030)
Figure 25. Europe Peramivir Revenue Market Share by Country (2019-2030)
Figure 26. Germany Peramivir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Peramivir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Peramivir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Peramivir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Peramivir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Peramivir Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Peramivir Revenue Market Share by Region (2019-2030)
Figure 33. China Peramivir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Peramivir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Peramivir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Peramivir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Peramivir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Taiwan Peramivir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Peramivir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Peramivir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Peramivir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Philippines Peramivir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Peramivir Sales Market Share by Country (2019-2030)
Figure 44. Latin America Peramivir Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Peramivir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Peramivir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Peramivir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Peramivir Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Peramivir Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Peramivir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Peramivir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Peramivir Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Peramivir by Type (2019-2030)
Figure 54. Global Revenue Market Share of Peramivir by Type (2019-2030)
Figure 55. Global Peramivir Price (US$/Kg) by Type (2019-2030)
Figure 56. Global Sales Market Share of Peramivir by Application (2019-2030)
Figure 57. Global Revenue Market Share of Peramivir by Application (2019-2030)
Figure 58. Global Peramivir Price (US$/Kg) by Application (2019-2030)
Figure 59. Peramivir Value Chain
Figure 60. Peramivir Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
